Format

Send to

Choose Destination
Dermatol Clin. 2010 Apr;28(2):361-6, xii. doi: 10.1016/j.det.2010.02.003.

Gene therapy for recessive dystrophic epidermolysis bullosa.

Author information

1
Institut National de la santé et de la recherche médicale, U563, Toulouse France.

Abstract

Among the severe genetic disorders of the skin that are suitable for gene and cell therapy, most efforts have been made in the treatment of blistering diseases including dystrophic epidermolysis bullosa. This condition can be recessively or dominantly inherited, depending on the nature and position of the mutation or mutations in the gene encoding type VII collagen. At present, there is no specific treatment for recessive dystrophic epidermolysis bullosa, and gene and cell therapy approaches hold great promise. This article discusses the different gene therapy approaches that have been used for the treatment of this disease and the new perspectives that they open.

PMID:
20447504
DOI:
10.1016/j.det.2010.02.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center